Wednesday, December 14, 2011
A researcher who specializes in low-tar cigarette studies is facing growing criticism after being honored with a seat in the elite Chinese Academy of Engineering, which health experts say only serves to discredit the country’s tobacco-control efforts. Xie Jianping, 52, is known for his research on low-tar cigarettes and serves as the deputy head of a tobacco research institute under China National Tobacco Corporation (China Tobacco) — China’s tobacco monopoly and the world’s largest cigarette company. Gan Quan, a senior project officer with the International Union Against Tuberculosis and Lung Disease, said it is an international common practice that science and research institutes should distance themselves from tobacco interests.
Tuesday, December 13, 2011
A recently elected member of the Chinese Academy of Engineering (CAE) is under scrutiny by tobacco control advocates for his research on reducing the impact of smoking on health. Xie Jianping’s appointment has been met with opposition because he is also the deputy director of the Zhengzhou Tobacco Research Institute under the China National Tobacco Corporation, the Beijing Times reported.
Tuesday, December 13, 2011
Chinese health officials and commentators have assailed one of the country’s most prestigious academic bodies for recruiting a scientist who specialized in refining low-tar cigarettes — at a time when the government has said it is fighting smoking. Xie Jianping, 52, who works for a research institute of the state-owned China National Tobacco Corporation, has been called the “Killer Academician” and “Tobacco Academician” on Chinese Internet sites after he was elected to the Chinese Academy of Engineering, an honorary body that also advises the government
Sunday, December 11, 2011
the official Chinese Academy of Engineering released the list of 54 new academicians. Only an hour later, Jinyuan Shi Xie Jianping new title will be on the Internet is “killing fellow” “Academy of Tobacco”, which is something that he did not expect. As the China National Tobacco Corporation, Zhengzhou Tobacco Research Institute, Xie Jianping is the main direction of the cigarette “tar harm reduction” research
Friday, November 25, 2011
Aim To examine the effectiveness of a stage-matched smoking cessation counselling intervention for smokers who had cardiac diseases Methods 1860 Chinese cardiac patients who smoked at least 1 cigarette in the past 7 days and aged 18 or above recruited from cardiac outpatient clinics of Hong Kong hospitals were randomly allocated to an intervention or control group. The intervention group (n = 938) received counselling matched with their stage of readiness to quit by trained-counsellors at baseline, 1-week, and 1-month. The control group (n = 922) received a brief counselling on healthy diet at baseline
Filed in Evidence Base, tobacco
|
Also tagged 12-month-follow, above-recruited, baseline, chinese, control-group, effectiveness, hospitals-were, intervention, promote-smoking, smoked-at-least, stages, the-12-month, tobacco
|
Tuesday, September 20, 2011
IntroductionIn China, illicit drug use and addiction have been rapidly increasing over the last two decades. Traditional compulsory rehabilitation models in China are widely considered ineffective.
Filed in Harm Reduction
|
Also tagged before-entering, city, compulsory, countries, national-policy, opportunity, program, rates-as-yulu, shequ, shequ-program, through-on-site
|
ABSTRACT Aims To describe some of the variability across the world in levels of quit smoking attempts and use of various forms of cessation support. Design Use of the International Tobacco Control Policy Evaluation Project surveys of smokers, using the 2007 survey wave (or later, where necessary)
Thursday, August 18, 2011
Abstract: Background: Buprenorphine/naloxone (BUP/NX) is not licenced for use in China or Thailand and there was little clinical experience with this drug combination in these countries at the inception of HIV Prevention Trial Network (HPTN) 058, a randomized trial comparing risk reduction counselling combined with either short-term or long-term medication assisted treatment with BUP/NX to prevent HIV infection and death amongst opioid-dependent injectors.Methods: We conducted a safety phase that included the first 50 subjects enrolled at each of the three initial study sites (N=150).
Filed in Evidence Base
|
Also tagged buprenorphine, chinese, comparing-risk, inception, network, prevention, reducing-opioid, study, study-subjects, term-or-long, these-countries, trial-network
|
ABSTRACT Aim To obtain information on drinking behaviour and to examine the associations between frequency of drinking, usual daily drinking quantity and binge drinking behaviour among Chinese residents aged 15–69 years. Design A multi-stage clustering sampling method was used to select a nationally representative sample and data were collected as part of the China Chronic Disease and Risk Factor Surveillance by face-to-face interview
A nationwide study confirms that binge drinking has reached epidemic proportions in China and argues that efforts to tackle the problem must address the country’s unique drinking culture…